Corcept Therapeutics Incorporated · NASDAQ:CORT
Mahoney David L sold 103,606 Corcept Therapeutics Incorporated shares (Form 4)
Traded Aug 18, 2026 · Filed Aug 20, 2026
On Aug 18, 2026, Mahoney David L (Director) sold 103,606 Corcept Therapeutics Incorporated shares at an average US$118.25 for US$12.3M under a trading plan, leaving 1,133,539 shares. Filed Aug 20, 2026 (Form 4).
- Sold
- 103,606 shares
- Price
- US$118.25 average (US$117.47 to US$119.64)
- Value
- US$12.3M
- Holding after
- 1,133,539 shares (held indirectly)
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 18, 2026 | Common Stock | Sale | 4,984 | US$117.47 | 1,232,161 | Indirect |
| Aug 18, 2026 | Common Stock | Sale | 91,167 | US$118.24 | 1,140,994 | Indirect |
| Aug 18, 2026 | Common Stock | Sale | 7,055 | US$118.88 | 1,133,939 | Indirect |
| Aug 18, 2026 | Common Stock | Sale | 400 | US$119.64 | 1,133,539 | Indirect |
Source
Related
- Corcept Therapeutics Incorporated
- Mahoney David L
- Corcept Therapeutics Incorporated shareholders
- Form 4 · Mahoney David L · Jun 18, 2026
- Form 4 · Wilson James N · Oct 16, 2026
- Form 4 · Vieira Roberto Wandenkolk · Oct 5, 2026
- Form 4 · Maduck Sean · Oct 5, 2026
- Form 4 · Lyon Joseph Douglas · Oct 5, 2026
- Form 4 · Robb Gary Charles · Sep 28, 2026